AAM
EW icon

Ardevora Asset Management’s Edwards Lifesciences EW Stock Holding History

Ardevora Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$10.6M Sell
139,106
-124,323
-47% -$8.65M 0.94% 56
2023
Q3 		$18.3M Buy
+263,429
New +$21.2M 0.9% 48
2022
Q4 		– Sell
-508,053
Closed -$42M – 144
2022
Q3 		$42M Sell
508,053
-44,329
-8% -$4.27M 0.76% 68
2022
Q2 		$52.5M Buy
552,382
+15,100
+3% +$1.56M 0.86% 67
2022
Q1 		$63.2M Sell
537,282
-58,637
-10% -$6.58M 0.82% 51
2021
Q4 		$77.2M Buy
595,919
+17,400
+3% +$2.03M 0.82% 48
2021
Q3 		$65.5M Sell
578,519
-94,800
-14% -$10.8M 0.83% 71
2021
Q2 		$69.7M Buy
673,319
+128,219
+24% +$12.1M 0.88% 58
2021
Q1 		$45.6M Sell
545,100
-50,000
-8% -$4.23M 0.68% 107
2020
Q4 		$54.3M Buy
+595,100
New +$49.4M 0.84% 83
2020
Q2 		– Sell
-1,200
Closed -$75K – 118
2020
Q1 		$75K Sell
1,200
-671,523
-100% -$48.4M ﹤0.01% 107
2019
Q4 		$52.3M Buy
672,723
+70,200
+12% +$5.48M 1.18% 37
2019
Q3 		$44.2M Sell
602,523
-86,400
-13% -$6.07M 1.23% 9
2019
Q2 		$42.4M Buy
688,923
+81,900
+13% +$4.95M 1.04% 29
2019
Q1 		$38.7M Sell
607,023
-111,000
-15% -$6.33M 1.01% 15
2018
Q4 		$36.7M Buy
718,023
+33,375
+5% +$1.69M 1.1% 7
2018
Q3 		$39.7M Sell
684,648
-22,200
-3% -$1.09M 1.1% 1
2018
Q2 		$34.3M Sell
706,848
-241,752
-25% -$11.3M 0.96% 42
2018
Q1 		$44.1M Buy
948,600
+1,800
+0.2% +$78.2K 1.32% 4
2017
Q4 		$35.6M Buy
946,800
+20,400
+2% +$749K 1.07% 43
2017
Q3 		$33.8M Buy
+926,400
New +$35.3M 1.01% 57
2016
Q1 		– Sell
-612,600
Closed -$16.1M – 96
2015
Q4 		$16.1M Buy
612,600
+232,200
+61% +$6.03M 1.07% 60
2015
Q3 		$9.01M Buy
380,400
+79,200
+26% +$1.91M 1.31% 42
2015
Q2 		$7.15M Buy
301,200
+15,600
+5% +$352K 1.24% 41
2015
Q1 		$6.78M Sell
285,600
-107,400
-27% -$2.41M 1.28% 56
2014
Q4 		$8.34M Buy
+393,000
New +$7.9M 1.81% 17

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ardevora Asset Management's EW Position: Q4 2023 in Review

Ardevora Asset Management reduced its Edwards Lifesciences (EW) stake by 47% in Q4 2023, selling an estimated $8.65M and leaving 139,106 shares worth $10.6M. The position accounts for 0.94% of the portfolio, ranked #56.

Ardevora Asset Management first reported a position in EW in Q4 2014 and has held it in 26 quarters since. The position peaked at $77.2M in Q4 2021. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Ardevora Asset Management held 139,106 shares of Edwards Lifesciences worth $10.6M as of Q4 2023.
  • Ardevora Asset Management sold 124,323 Edwards Lifesciences shares in Q4 2023, an estimated $8.65M.
  • Edwards Lifesciences made up 0.94% of Ardevora Asset Management's portfolio in Q4 2023, its #56 holding.
  • Ardevora Asset Management first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 26 quarters since.
  • Ardevora Asset Management's Edwards Lifesciences position peaked at $77.2M in Q4 2021.
  • 1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Ardevora Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.